J. Méndez

Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.

C. Grande, P. Iglesias, J. Díez, 2001, Thyroid : official journal of the American Thyroid Association.

Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.

R. Selgas, P. Iglesias, J. Díez, 1994, Kidney international.

Evaluation of Thyroid Function in Patients Treated with Continuous Ambulatory Peritoneal Dialysis (CAPD)

R. Selgas, L. Sanchez-Sicilia, P. González-Gancedo, 1983 .

Growth hormone, IGF‐I and its binding proteins (IGFBP‐1 and ‐3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis

R. Selgas, M. Bajo, P. Iglesias, 2004, Clinical endocrinology.

Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.

R. Selgas, P. Iglesias, J. Díez, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.

R. Selgas, P. Iglesias, J. Díez, 1999, Metabolism: clinical and experimental.

Growth hormone and insulin‐like growth factor binding protein‐1 responses to oral glucose in patients with primary hyperparathyroidism

C. Grande, P. Iglesias, J. Díez, 2006, Clinical endocrinology.

Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients.

R. Selgas, P. Iglesias, J. Díez, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.